Clinical trials in the genomic era: effects of protective genotypes on sample size and duration of trial.
about
Genotype-based risk and pharmacogenetic sampling in clinical trialsPharmacogenetics: the ethical context.SNPs--where's the beef?A pharmacogeneticist's look at drug effects and the drug development process: an overview.Rare genetic variants and treatment response: sample size and analysis issues.Biochemie und Molekulargenetik 2001
P2860
Clinical trials in the genomic era: effects of protective genotypes on sample size and duration of trial.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Clinical trials in the genomic ...... le size and duration of trial.
@en
Clinical trials in the genomic ...... le size and duration of trial.
@nl
type
label
Clinical trials in the genomic ...... le size and duration of trial.
@en
Clinical trials in the genomic ...... le size and duration of trial.
@nl
prefLabel
Clinical trials in the genomic ...... le size and duration of trial.
@en
Clinical trials in the genomic ...... le size and duration of trial.
@nl
P2093
P1476
Clinical trials in the genomic ...... le size and duration of trial.
@en
P2093
P356
10.1016/S0197-2456(99)00039-2
P407
P577
2000-02-01T00:00:00Z